Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
14.44 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
14.44 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
14.44 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.93 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.41 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.41 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.40 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17308373 17451421 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.72 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.69 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.69 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.57 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Kaolin |
5.98 | 17392412 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.10 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 18558336 18177632 18985861 16609825 18316065 19460635 20603192 18396377 15238991 18940202 17507914 19232924 18775368 17688650 17157402 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.08 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.05 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.03 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.03 | 8888407 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.49 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.35 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.35 | 16595493 19217205 18608205 18357371 16557594 15136595 16110121 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.35 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.35 | 17242785 16912660 15775269 17893378 16837676 17049068 17595753 15758505 17261762 17440819 17952589 15572757 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.70 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.19 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.59 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.59 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.59 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.59 | 17971768 17045692 17088986 18930000 16332177 16799960 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.02 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.64 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.64 | 16757204 18986760 17066447 16280240 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.08 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
7.82 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.82 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.58 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.58 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.71 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.92 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 15340226 12621046 8697196 15668235 16354765 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.23 | 18772588 17725105 17287894 15001691 17016597 16510598 17018589 17172411 16340194 17169374 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.93 | 17016601 16524972 17594712 20501625 17255274 18383874 18949393 16331619 18288408 16303861 18448328 17401013 16391804 17695437 17094418 18802399 15289873 18509181 14970324 17454858 15148649 16282729 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
2.93 | 17116718 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.87 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.87 | 16575769 8888407 17688650 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.94 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.94 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.24 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.81 | 16733453 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.13 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
3.94 | 17451421 15920148 17308373 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.98 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.98 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.98 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.98 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.06 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.87 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.87 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.01 | 15845917 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.17 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.95 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.94 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.59 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.31 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.08 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.49 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.49 | 17638652 16785472 16337965 16481741 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005175 |
Factor XII Deficiency |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.21 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
13.21 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.21 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.92 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.14 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.53 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.53 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.87 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.16 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.39 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.45 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.45 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.91 | 15340226 12621046 16120746 |
MESH:D056828 |
Hereditary Angioedema Type III |
marker/mechanism |
|
| |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
5.01 | 14716179 17290160 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.59 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.59 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.59 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.64 | 16612254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.86 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.34 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.78 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.78 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.78 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.78 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.11 | 9562676 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.70 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.25 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.25 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.25 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
14.25 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.25 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.81 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.81 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.81 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
11.57 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
11.57 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.84 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.84 | 6695378 17053015 20064080 20464547 20135361 20869020 18520028 18816296 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.84 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.84 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.81 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.95 | 17352296 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.19 | 18765137 18803445 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.54 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.54 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.30 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.44 | 16497877 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.03 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.15 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.41 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.41 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.07 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.07 | 18600527 16928823 18239605 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.13 | 16359493 8888407 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.44 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.90 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.90 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.65 | 16562857 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.65 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 15758505 17893378 17823083 15579764 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.66 | 15113037 16929163 16500647 19003803 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.53 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.53 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.14 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.14 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.14 | 16365062 17571952 17219775 17374662 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.14 | 16220300 15731164 16536755 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.57 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.91 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.91 | 17410198 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.01 | 15538739 18722050 16160472 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.72 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.18 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.83 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.83 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.83 | 3137016 16876388 15475178 17978042 1511512 11738929 11044598 14763951 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.48 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.48 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.78 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.57 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.42 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.42 | 17522103 16424979 18396642 19015929 19084572 17498489 16951190 15786421 17172411 18567086 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.82 | 16837676 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.04 | 9562676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.24 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.99 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.26 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.54 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.94 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.94 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.94 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.94 | 17572228 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.66 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.06 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.06 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.88 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |